Pharma IQ Members

Global Pharmaceutical Serialisation – Are You Prepared?
Cold Chain podcast

Johannes Schoen on the EU Falsified Medicines Directive, Weak Links & Top Tips for Improving Supply Chain Visibility

Hosted By: Andrea Charles
Rate this Podcast: 
Average: 6 (4 votes)

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product.

To continue viewing this content please fill out the form below and become an Cold Chain IQ member.
Or if you're already a Cold Chain IQ member, sign in below to download.
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Forgot your password?

Or log in with...

Not a member?

Reasons for Joining
  • Address your challenges through knowledge sharing with peers from our global network of specialists.
  • Benchmark your business initiatives with the who's who in the field.
  • Hear from industry pioneers how to maximize ROI in today's challenging economy.
  • And best of all It's FREE!
About this Podcast...

In this interview Johannes Schoen, Senior Manager, Anti-Counterfeiting at Boehringer Ingelheim, speaks to Andrea Charles from Cold Chain IQ, about the key uncertainties surrounding pharmaceutical serialisation and the impact recent serialisation initiatives will have on the pharma industry. Schoen also shares his thoughts on the implications the EU directive on falsified medicines will have the generics market and his top tips for improving supply chain visibility.

Have Your Say
Rate this feature and give us your feedback in the comments section below